🔗 Share this article

As America undertakes unprecedented changes to its vaccination recommendations, a particular individual has emerged in a surprising turn: Høeg, an American of Danish descent sports physician and public health researcher who rose to prominence by expressing skepticism about COVID-19 vaccinations throughout the global health crisis and has concentrated on potential fatalities after COVID-19 vaccination in her brief tenure at the Food and Drug Administration.

Proposed Changes to Childhood Immunization Schedule

Agency leaders planned to unveil sweeping changes to the childhood immunization program recently, bringing the US with Denmark’s national calendar, sources say – a substantial departure that would place the US out of alignment with a large portion of the global community with insufficient data for benefit. The planned update has been delayed until the coming year.

In place of Vinay Prasad, Høeg is set to address the audience at the gathering. She was just designated acting director of the FDA’s CDER, the fifth person to run the center this year.

A Shift at the Agency

The acting appointment might represent a tighter collaboration between the pharmaceutical and vaccine divisions as Dr. Høeg and Dr. Prasad strengthen their influence at the FDA – and it points to a greater focus upon reevaluating previously authorized vaccines at the FDA.

Høeg has repeatedly called for halting some childhood shot schedules in the US in order to be more in line with Denmark's approach, a nation with comprehensive healthcare and a population roughly the size of Wisconsin’s.

In her initial comments, she has persisted in emphasizing on immunizations – typically the responsibility of Dr. Prasad, director of the FDA’s CBER – instead of pharmaceutical oversight.

Questions Over Background

Dr. Høeg has little discernible background in pharmaceutical research, approval processes or management, which has been typical for previous heads of the CBER. She has worked at the FDA as a key advisor to the FDA chief and the vaccine center since earlier this year.

“It seems she lacks to have the necessary background” for running the drug-regulation department, said a neurologist and psychiatrist. “She’s never run a scientific study. She lacks experience in running a large organization. She lacks background in pharmaceutical oversight.”

Past heads of the center would “grasp regulatory frameworks and the science of medication creation”, noted Janet Woodcock. “Objectively, she has not acquired the kind of background that previous people who led the center have had.”

CDER has an vast workload at the FDA, the former commissioner stated.

“Everybody just focuses on the innovative therapies, but the generic program clears a multitude of generic medications. There is also a biosimilars program, over-the-counter program and more, and all of those need to be supervised,” Dr. Woodcock noted. “The responsibility you neglect, that’s the thing that I always told people is going to come back to haunt you.”

There is also, a significant administrative aspect to the job, which manages more than 5,000 employees. “It is a massive management job, if you do it right,” Woodcock added.

Response and Contentious Policies

Regarding questions about Høeg’s qualifications and whether this selection signifies greater collaboration among agency officials on vaccines, a spokesperson stated that the “concerns rely on flawed assumptions”.

“Her resume matches the functions of her position,” the spokesperson said, noting the time Høeg spent advising the agency head on “medication safety and oversight research, including computational safety modeling and vaccine surveillance”.

In her interim role, Dr. Høeg assumes responsibility for the agency head's controversial fast-track approval initiative, a contentious one-day therapy clearance system that allegedly concerned her former heads. “How are these therapies being chosen for this fast-track system? Who takes the decisions?” Howard asked. “There’s a lot of confidentiality occurring at the FDA right now.”

Overall, he remarked, “the agency appears to be shifting towards more relaxed regulations of most medications, except for shots.”

Established History on Vaccines

Regarding vaccines, Dr. Høeg has a clearer, if troubling, history, Howard said. She published a research paper using non-validated crowd-sourced reports to estimate the incidence of myocarditis after COVID-19 vaccination. She consulted for the state of Florida chief medical officer Dr. Joseph Ladapo, who reportedly have altered data to indicate Covid vaccinations are pose a greater threat than they are.

Part of her “policy goals” for the new federal leadership included changing guidelines for new vaccines and ending “non-essential” vaccines, she remarked after the election on a audio program. At the agency, Høeg has according to sources floated the idea of barring adolescent males from getting COVID-19 vaccinations.

“She is an all-around true believer who begins with her conclusions and works backwards to retrofit the science in a very deceptive, untruthful fashion,” Howard stated.

Taking Control and a “Revenge Tour”

Høeg aligned with fellow skeptics, {like|